Published recall report · ImpurityUpdated · 1 yr 7 mo ago
Glenmark Pharmaceuticals Inc., USA recall: Atomoxetine Capsules, USP, 18 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-266-30.
Atomoxetine Capsules, USP, 18 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-266-30.
Current recall status is unverified. FDA does not update drug-enforcement status after publication. Check the latest official information or ask a pharmacist.
What to do
Check the lot number on your pack against this recall and follow the firm's instructions. Do not stop taking a prescribed medicine without talking to a pharmacist or doctor first.
FDA public enforcement report, opens in a new tabWhich products
Atomoxetine Capsules, USP, 18 mg, 30 capsule bottles, Rx Only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA, Product of India, NDC 68462-266-30.
- Producer
- Glenmark Pharmaceuticals Inc., USA
- Brand
- ATOMOXETINE
Numbers
- Dates on pack
- Lot Numbers: 19233756, Exp.: 8/2025; 19235111, Exp.: 11/2025; 19242167, Exp.: 5/2026; 19242180, Exp.: 5/2026.
0368462265307
0368462270301
0368462267301
0368462271308
0368462268308
0368462269305
0368462266304
More detail
CGMP Deviations: presence of N-Nitroso Atomoxetine Impurity above the FDA recommended limit.
In the news
Reporting from news publishers. Follow the official notice for product advice.
No news stories about this recall yet.